These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28919544)

  • 1. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
    Remmler J; Schneider C; Treuner-Kaueroff T; Bartels M; Seehofer D; Scholz M; Berg T; Kaiser T
    Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin - a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease.
    Schneider C; Remmler J; Netto J; Seehofer D; Engelmann C; Berg T; Thiery J; Kaiser T
    Clin Chem Lab Med; 2019 Nov; 57(12):1897-1905. PubMed ID: 31199758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio Associates Independently With Mortality in Hospitalized Patients With Cirrhosis.
    Rice J; Dodge JL; Bambha KM; Bajaj JS; Reddy KR; Gralla J; Ganapathy D; Mitrani R; Reuter B; Palecki J; Acharya C; Shaw J; Burton JR; Biggins SW
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1786-1791.e1. PubMed ID: 29705264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
    Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Chen W; You J; Chen J; Zheng Q; Jiang JJ; Zhu YY
    World J Gastroenterol; 2017 Oct; 23(40):7303-7309. PubMed ID: 29142477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis.
    Antunes AG; Teixeira C; Vaz AM; Martins C; Queirós P; Alves A; Velasco F; Peixe B; Oliveira AP; Guerreiro H
    Gastroenterol Hepatol; 2017 Apr; 40(4):276-285. PubMed ID: 28222896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
    Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.
    Szyguła-Jurkiewicz B; Nadziakiewicz P; Zakliczynski M; Szczurek W; Chraponski J; Zembala M; Gasior M
    Transplant Proc; 2016 Jun; 48(5):1756-60. PubMed ID: 27496486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Model for End-Stage Liver Disease-Serum Sodium Scores in Predicting Complication Severity Grades After Liver Transplantation for Acute-on-chronic Liver Failure.
    Zhang QK; Wang ML
    Transplant Proc; 2019 Apr; 51(3):833-841. PubMed ID: 30979472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.
    Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J
    Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome.
    Sonika U; Jadaun S; Ranjan G; Rout G; Gunjan D; Kedia S; Nayak B; Shalimar
    Indian J Gastroenterol; 2018 Jan; 37(1):50-57. PubMed ID: 29476404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
    Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS
    J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis.
    Lee HA; Jung JY; Lee YS; Jung YK; Kim JH; An H; Yim HJ; Jeen YT; Yeon JE; Byun KS; Um SH; Seo YS
    Gut Liver; 2021 Jul; 15(4):599-605. PubMed ID: 33293481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease and pneumonia: An improved scoring model for critically ill cirrhotic patients with pneumonia.
    Gao F; Cai MX; Lin MT; Zhang LZ; Ruan QZ; Gao F
    Turk J Gastroenterol; 2019 Jun; 30(6):532-540. PubMed ID: 31144659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.